Auro Laboratories P/E Ratio
Auro Laboratories (AUROLAB) P/E ratio is 84.75 (High), EPS (TTM) ₹2.95, current price ₹243.35 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Auro Laboratories stock price NSE .
Current P/E Ratio
84.75
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
84.75
Current Price
₹243.35
EPS (TTM)
₹2.95
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.44
Sector Median
27.37
Sector Rank
#11 of 192
Sector Percentile
5.7%
Earnings Breakdown (TTM)
TTM EPS
₹2.76
Sept 2025
₹1.15
Jun 2025
₹-0.17
AUROLAB P/E Ratio — Valuation Signal & Historical Context
Auro Laboratories P/E 84.75 — signal: Overvalued. Analyse AUROLAB shareholder distribution to track promoter, FII and institutional holdings.
- Stock appears overvalued with PE of 84.75, suggesting caution for new investments
- Trading at premium to sector average PE of 53.44
AUROLAB vs Healthcare Peers — P/E Ratio Comparison
Auro Laboratories P/E 84.75 vs Healthcare average 53.44, median 27.37 — range 1.03–1007.14.
Sector Average
53.44
Sector Median
27.37
Lowest P/E
1.03
Highest P/E
1007.14
Companies
192
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.03 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 4.19 | ₹71 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.7 | ₹1,105 | Low |
| Amwill Health Care | AMWILL | 6.71 | ₹71 | Low |
| Shelter Pharma | SHELTER | 6.75 | ₹49 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹23 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹74 | Low |
| Par Drugs & Chemical | PAR | 8.21 | ₹114 | Low |
| Medicamen Organics | MEDIORG | 8.76 | ₹35 | Low |